Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact Us
Customer Login
 


Headlines
 

07/29 22:04   Patriarch Kirill calls murders of priest and nun in Kyiv outrageous (Part 2)
 
07/29 22:00   Over 30 foreign yachts enter Crimea since beginning of summer
 
07/29 21:52   Court ruling to arrest Pivovarov groundless - PARNAS activists
 
07/29 21:50   Kyiv's statements on detention of allegedly Russian serviceman call for no comment - Peskov
 
07/29 21:49   Moscow appreciates efforts of foreign funds to promote democracy but won't tolerate interference - Foreign Ministry (Part 2)
 
07/29 21:48   PARNAS activist Pivovarov arrested by Kostroma court for two months
 
07/29 21:30   Mariupol defense not to be loosened - Ukrainian authorities
 
07/29 21:22   Western sanctions didn't prevent Almaz-Antey from improving its world market position - CEO
 
07/29 21:06   Ukrainian Prosecutor General's Office asks U.S. to help searching for foreign accounts of Yanukovych regime reps
 
07/29 20:28   Ukrainian Prosecutor General's Office has no confirmation of Yanukovych's location
 




 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

July 29, 2015
 
22:04
Patriarch Kirill calls murders of priest and nun in Kyiv outrageous (Part 2)
 
22:00
Over 30 foreign yachts enter Crimea since beginning of summer
 
21:52
Court ruling to arrest Pivovarov groundless - PARNAS activists
 
21:50
Kyiv's statements on detention of allegedly Russian serviceman call for no comment - Peskov
 
21:49
Moscow appreciates efforts of foreign funds to promote democracy but won't tolerate interference - Foreign Ministry (Part 2)
 
21:48
 
21:30
Mariupol defense not to be loosened - Ukrainian authorities
 
21:22
Western sanctions didn't prevent Almaz-Antey from improving its world market position - CEO
 
21:06
Ukrainian Prosecutor General's Office asks U.S. to help searching for foreign accounts of Yanukovych regime reps
 
20:28
Ukrainian Prosecutor General's Office has no confirmation of Yanukovych's location
 
20:16
Radio frequencies committee confirms new spectrum sharing in LTE, launching it on Oct 1
 
20:05
Sberbank considering placement of structured bonds in various currencies
 
20:02
Dollar, euro fall on Wed, ruble growing thanks to actions of Central Bank, oil's rise
 
19:54
OPERATORS RECEIVE OPPORTUNITY TO JOINTLY USE RADIO FREQUENCIES FROM OCT 1 - MINISTRY
 
 more headlines 



Interviews
 

.
North Korean Ambassador to Russia Kim Hyun Joon has given an interview to Interfax in which he speaks about differences between the Korean Peninsula nuclear problem and the Iranian nuclear dossier, states Pyongyang‘s readiness to bolster its nuclear potential in response to U.S. actions and calls on Washington not to hold joint exercises with South Korea.

more
.
.
OSCE Parliamentary Assembly Director of Communications Richard Solash has given an interview to Interfax in which he speaks about how the ban for Russian State Duma speaker Sergei Naryshkin to enter Finland for the summer session of the OSCE Parliamentary Assembly may impact the session and what this Finland‘s decision may lead to in current conditions.

more
.
.
Head of Operations for Europe and Central Asia of the International Committee of the Red Cross Laurent Corbaz has given an interview with Interfax in which he speaks about the activity of the ICRC in eastern Ukraine and problems that ICRC officials face there, as well as interaction with Russian authorities on humanitarian aid and situation with Ukrainian refugees.

more

 
  
 ©   1991—2015   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100